Skip to main content
. 2018 Apr 5;20(9):1240–1250. doi: 10.1093/neuonc/noy053

Fig. 4.

Fig. 4.

Survival analysis results for newly diagnosed GBM patients treated with standard chemoradiation plus experimental therapy. (A) Kaplan–Meier survival plots demonstrating a longer OS in patients with small postoperative enhancing tumors (<12 mL) prior to chemoradiation plus bevacizumab in the experimental treatment arm of AVAglio. (B) Similarly, Kaplan–Meier survival plots demonstrating a longer OS in patients with small enhancing tumors (<12 mL) prior to treatment with chemoradiation plus vorinostat in Alliance N0874.